The abstract is read at the publisher; the summary is JClub's.
In >46,000 UK Biobank participants, genetically driven TRL/remnants and lipoprotein(a) each associate with chemokine-signaling and leukocyte-chemotaxis proteins, unlike LDL, and a shared chemokine signature explains ~40% of TRL/remnant cholesterol–CVD linkage.
- Why it matters: TRL and lipoprotein(a) are more per-particle atherogenic than LDL, but the protein pathways connecting them to cardiovascular disease risk are not well defined.
- What they did: Using Mendelian randomization, the study tested genetically determined TRL/remnants, LDL, and lipoprotein(a) against 2,920 plasma proteins, identifying causal links with 432, 58, and 111 proteins, respectively.
- The result: A specific chemokine signature shared by TRL/remnants and lipoprotein(a) accounted for ~40% (wide confidence limits) of the TRL/remnant cholesterol–CVD association, while a general chemokine-to-CVD relationship independent of TRL/Lp(a) was not supported.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.